A comprehensive view of amgen inc.. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Amgen Inc. Champions Preventive Healthcare, Community Education, and Biotechnological Innovation in Recent Social Media Highlights
Published:
April 26, 2024
by Industry Intelligence Inc.
|
European Patent Office Receives Amgen Inc's Patent Application for Engineered NRG-1 Variants with Improved Selectivity Toward Erbb4 But Not Against ERBB3
Published:
April 25, 2024
by Pharmaceutical Patent News
|
Amgen Inc Submits European Patent Application for Assessing Packed Cell Volume for Cell Cultures
Published:
April 25, 2024
by Biotechnology Patent News
|
Amgen Inc Seeks Patent for Using Fucosidase to Control Afucosylation Level of Glycosylated Proteins
Published:
April 25, 2024
by Biotechnology Patent News
|
European Patent Office Receives Amgen Inc's Patent Application for Drug Delivery Devices, Finger-Grip Elements, and Related Methods
Published:
April 25, 2024
by Pharmaceutical Patent News
|
Ask us about our Health Care Sector market view